{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:22:44Z","timestamp":1788906164889,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T00:00:00Z","timestamp":1416873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00281-014-0459-z","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T10:36:04Z","timestamp":1417516564000},"page":"153-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pathological and protective immunity to Pneumocystis infection"],"prefix":"10.1007","volume":"37","author":[{"given":"Taylor","family":"Eddens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay K.","family":"Kolls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,25]]},"reference":[{"key":"459_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1567-1364.2010.00698.x","volume":"11","author":"M Chabe","year":"2011","unstructured":"Chabe M et al (2011) Pneumocystis: from a doubtful unique entity to a group of highly diversified fungal species. FEMS Yeast Res 11:2\u201317","journal-title":"FEMS Yeast Res"},{"key":"459_CR2","first-page":"250","volume":"30","author":"Centers for Disease C","year":"1981","unstructured":"Centers for Disease C (1981) Pneumocystis pneumonia\u2014Los Angeles. MMWR Morb Mortal Wkly Rep 30:250\u2013252","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"459_CR3","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3201\/eid1010.030985","volume":"10","author":"A Morris","year":"2004","unstructured":"Morris A et al (2004) Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 10:1713\u20131720","journal-title":"Emerg Infect Dis"},{"key":"459_CR4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/526778","volume":"46","author":"PD Walzer","year":"2008","unstructured":"Walzer PD et al (2008) Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985\u20132006. Clin Infect Dis : Off Publ Infect Diseases Soc Am 46:625\u2013633","journal-title":"Clin Infect Dis : Off Publ Infect Diseases Soc Am"},{"key":"459_CR5","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1086\/597468","volume":"48","author":"C Cohort","year":"2009","unstructured":"Antiretroviral Therapy, Cohort C et al (2009) Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis 48:1138\u20131151","journal-title":"Clin Infect Dis"},{"key":"459_CR6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1513\/pats.201009-062WR","volume":"8","author":"L Huang","year":"2011","unstructured":"Huang L et al (2011) HIV-associated Pneumocystis pneumonia. Proc Am Thorac Soc 8:294\u2013300","journal-title":"Proc Am Thorac Soc"},{"key":"459_CR7","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(95)91862-0","volume":"346","author":"AS Malin","year":"1995","unstructured":"Malin AS et al (1995) Pneumocystis carinii pneumonia in Zimbabwe. Lancet 346:1258\u20131261","journal-title":"Lancet"},{"key":"459_CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00002030-200201040-00013","volume":"16","author":"DD Ruffini","year":"2002","unstructured":"Ruffini DD, Madhi SA (2002) The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS 16:105\u2013112","journal-title":"AIDS"},{"key":"459_CR9","first-page":"30","volume":"80","author":"JM Chakaya","year":"2003","unstructured":"Chakaya JM et al (2003) Pneumocystis carinii pneumonia in HIV\/AIDS patients at an urban district hospital in Kenya. East Afr Med J 80:30\u201335","journal-title":"East Afr Med J"},{"key":"459_CR10","first-page":"1469","volume":"36","author":"S Tansuphasawadikul","year":"2005","unstructured":"Tansuphasawadikul S et al (2005) Clinical features, etiology and short term outcomes of interstitial pneumonitis in HIV\/AIDS patients. Southeast Asian J Trop Med Public Health 36:1469\u20131478","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"Suppl 2","key":"459_CR11","first-page":"26","volume":"35","author":"V Nissapatorn","year":"2004","unstructured":"Nissapatorn V et al (2004) Spectrum of opportunistic infections among HIV-infected patients in Malaysia. Southeast Asian J Trop Med Public Health 35(Suppl 2):26\u201332","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"459_CR12","first-page":"437","volume":"53","author":"ZF Udwadia","year":"2005","unstructured":"Udwadia ZF et al (2005) Pneumocystis carinii pneumonia in HIV infected patients from Mumbai. J Assoc Physicians India 53:437\u2013440","journal-title":"J Assoc Physicians India"},{"key":"459_CR13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1130-1406(08)70054-8","volume":"25","author":"MM Panizo","year":"2008","unstructured":"Panizo MM et al (2008) Pneumocystosis in Venezuelan patients: epidemiology and diagnosis (2001\u20132006). Rev Iberoam Micol 25:226\u2013231","journal-title":"Rev Iberoam Micol"},{"key":"459_CR14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4067\/S0034-98872005000500002","volume":"133","author":"S Chernilo","year":"2005","unstructured":"Chernilo S et al (2005) Lung diseases among HIV infected patients admitted to the \u201cInstituto Nacional del Torax\u201d in Santiago, Chile. Rev Med Chil 133:517\u2013524","journal-title":"Rev Med Chil"},{"key":"459_CR15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jinf.2005.06.014","volume":"53","author":"L Mikaelsson","year":"2006","unstructured":"Mikaelsson L et al (2006) Pneumocystis pneumonia\u2014a retrospective study 1991\u20132001 in Gothenburg, Sweden. J Infect 53:260\u2013265","journal-title":"J Infect"},{"key":"459_CR16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3201\/eid1903.121151","volume":"19","author":"R Maini","year":"2013","unstructured":"Maini R et al (2013) Increasing Pneumocystis pneumonia, England, UK, 2000\u20132010. Emerg Infect Dis 19:386\u2013392","journal-title":"Emerg Infect Dis"},{"key":"459_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1753465810380102","volume":"5","author":"EM Carmona","year":"2011","unstructured":"Carmona EM, Limper AH (2011) Update on the diagnosis and treatment of Pneumocystis pneumonia. Ther Adv Respir Dis 5:41\u201359","journal-title":"Ther Adv Respir Dis"},{"key":"459_CR18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.idc.2009.10.010","volume":"24","author":"E Catherinot","year":"2010","unstructured":"Catherinot E et al (2010) Pneumocystis jirovecii Pneumonia. Infect Dis Clin N Am 24:107\u2013138","journal-title":"Infect Dis Clin N Am"},{"key":"459_CR19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-3062.2011.00691.x","volume":"13","author":"N Goto","year":"2011","unstructured":"Goto N, Oka S (2011) Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis 13:551\u2013558","journal-title":"Transpl Infect Dis"},{"key":"459_CR20","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1097\/QAD.0b013e328314b5f1","volume":"22","author":"C Mussini","year":"2008","unstructured":"Mussini C et al (2008) Patients presenting with AIDS in the HAART era: a collaborative cohort analysis. AIDS 22:2461\u20132469","journal-title":"AIDS"},{"key":"459_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/TP.0b013e3181aad256","volume":"88","author":"RT Neff","year":"2009","unstructured":"Neff RT et al (2009) Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia. Transplantation 88:135\u2013141","journal-title":"Transplantation"},{"key":"459_CR22","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","volume":"34","author":"KA Sepkowitz","year":"2002","unstructured":"Sepkowitz KA (2002) Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin Infect Dis 34:1098\u20131107","journal-title":"Clin Infect Dis"},{"key":"459_CR23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1600-6143.2010.03021.x","volume":"10","author":"RA Wolfe","year":"2010","unstructured":"Wolfe RA et al (2010) Trends in organ donation and transplantation in the United States, 1999\u20132008. Am J Transplant 10:961\u2013972","journal-title":"Am J Transplant"},{"key":"459_CR24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/CMR.17.4.770-782.2004","volume":"17","author":"M Rodriguez","year":"2004","unstructured":"Rodriguez M, Fishman JA (2004) Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev 17:770\u2013782, table of contents","journal-title":"Clin Microbiol Rev"},{"key":"459_CR25","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1002\/art.27735","volume":"62","author":"GH Louie","year":"2010","unstructured":"Louie GH et al (2010) Trends in hospitalizations for Pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the US: 1996\u20132007. Arthritis Rheum 62:3826\u20133827","journal-title":"Arthritis Rheum"},{"key":"459_CR26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3899\/jrheum.091426","volume":"37","author":"LK Stamp","year":"2010","unstructured":"Stamp LK, Hurst M (2010) Is there a role for consensus guidelines for P. jiroveci pneumonia prophylaxis in immunosuppressed patients with rheumatic diseases? J Rheumatol 37:686\u2013688","journal-title":"J Rheumatol"},{"key":"459_CR27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10067-006-0441-9","volume":"26","author":"ME Falagas","year":"2007","unstructured":"Falagas ME et al (2007) Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 26:663\u2013670","journal-title":"Clin Rheumatol"},{"key":"459_CR28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ibd.20261","volume":"14","author":"DM Poppers","year":"2008","unstructured":"Poppers DM, Scherl EJ (2008) Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care. Inflamm Bowel Dis 14:106\u2013113","journal-title":"Inflamm Bowel Dis"},{"key":"459_CR29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1705149","volume":"36","author":"N Castro De","year":"2005","unstructured":"De Castro N et al (2005) Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study. Bone Marrow Transplant 36:879\u2013883","journal-title":"Bone Marrow Transplant"},{"key":"459_CR30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1378\/chest.12-0477","volume":"144","author":"I Martin-Garrido","year":"2013","unstructured":"Martin-Garrido I et al (2013) Pneumocystis pneumonia in patients treated with rituximab. Chest 144:258\u2013265","journal-title":"Chest"},{"key":"459_CR31","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/cc6806","volume":"12","author":"X Monnet","year":"2008","unstructured":"Monnet X et al (2008) Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit Care 12:R28","journal-title":"Crit Care"},{"key":"459_CR32","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/rheumatology\/kes244","volume":"51","author":"S Mori","year":"2012","unstructured":"Mori S, Sugimoto M (2012) Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis. Rheumatology (Oxford) 51:2120\u20132130","journal-title":"Rheumatology (Oxford)"},{"key":"459_CR33","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","volume":"350","author":"CF Thomas Jr","year":"2004","unstructured":"Thomas CF Jr, Limper AH (2004) Pneumocystis pneumonia. N Engl J Med 350:2487\u20132498","journal-title":"N Engl J Med"},{"key":"459_CR34","doi-asserted-by":"crossref","first-page":"W555","DOI":"10.2214\/AJR.11.7329","volume":"198","author":"JP Kanne","year":"2012","unstructured":"Kanne JP et al (2012) Pneumocystis jiroveci pneumonia: high-resolution CT findings in patients with and without HIV infection. AJR Am J Roentgenol 198:W555\u2013W561","journal-title":"AJR Am J Roentgenol"},{"key":"459_CR35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0140-6736(90)92008-6","volume":"336","author":"AE Wakefield","year":"1990","unstructured":"Wakefield AE et al (1990) Detection of Pneumocystis carinii with DNA amplification. Lancet 336:451\u2013453","journal-title":"Lancet"},{"key":"459_CR36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/QCO.0b013e32834cac17","volume":"24","author":"AB Reid","year":"2011","unstructured":"Reid AB et al (2011) Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools. Curr Opin Infect Dis 24:534\u2013544","journal-title":"Curr Opin Infect Dis"},{"key":"459_CR37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1099\/jmm.0.45528-0","volume":"53","author":"P Flori","year":"2004","unstructured":"Flori P et al (2004) Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol 53:603\u2013607","journal-title":"J Med Microbiol"},{"key":"459_CR38","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/JCM.01756-09","volume":"47","author":"S Desmet","year":"2009","unstructured":"Desmet S et al (2009) Serum (1\u20133)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol 47:3871\u20133874","journal-title":"J Clin Microbiol"},{"key":"459_CR39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2169\/internalmedicine.48.1680","volume":"48","author":"H Nakamura","year":"2009","unstructured":"Nakamura H et al (2009) Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia. Intern Med 48:195\u2013202","journal-title":"Intern Med"},{"key":"459_CR40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/S0074-02762009000300004","volume":"104","author":"CM Aliouat-Denis","year":"2009","unstructured":"Aliouat-Denis CM et al (2009) The Pneumocystis life cycle. Mem Inst Oswaldo Cruz 104:419\u2013426","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"459_CR41","doi-asserted-by":"crossref","first-page":"e8524","DOI":"10.1371\/journal.pone.0008524","volume":"5","author":"MT Cushion","year":"2010","unstructured":"Cushion MT et al (2010) Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection. PLoS ONE 5:e8524","journal-title":"PLoS ONE"},{"key":"459_CR42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2307\/3283204","volume":"80","author":"CA Itatani","year":"1994","unstructured":"Itatani CA (1994) Ultrastructural demonstration of a pore in the cyst wall of Pneumocystis carinii. J Parasitol 80:644\u2013648","journal-title":"J Parasitol"},{"key":"459_CR43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tim.2004.03.005","volume":"12","author":"MT Cushion","year":"2004","unstructured":"Cushion MT (2004) Pneumocystis: unraveling the cloak of obscurity. Trends Microbiol 12:243\u2013249","journal-title":"Trends Microbiol"},{"key":"459_CR44","doi-asserted-by":"crossref","first-page":"e20935","DOI":"10.1371\/journal.pone.0020935","volume":"6","author":"A Martinez","year":"2011","unstructured":"Martinez A et al (2011) Ploidy of cell-sorted trophic and cystic forms of Pneumocystis carinii. PLoS ONE 6:e20935","journal-title":"PLoS ONE"},{"key":"459_CR45","doi-asserted-by":"crossref","first-page":"e79958","DOI":"10.1371\/journal.pone.0079958","volume":"8","author":"A Martinez","year":"2013","unstructured":"Martinez A et al (2013) Growth and airborne transmission of cell-sorted life cycle stages of Pneumocystis carinii. PLoS ONE 8:e79958","journal-title":"PLoS ONE"},{"key":"459_CR46","doi-asserted-by":"crossref","unstructured":"Schildgen V et al. 2014. Pneumocystis jirovecii can be productively cultured in differentiated CuFi-8 airway cells. MBio 5","DOI":"10.1128\/mBio.01186-14"},{"key":"459_CR47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/334519a0","volume":"334","author":"JC Edman","year":"1988","unstructured":"Edman JC et al (1988) Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334:519\u2013522","journal-title":"Nature"},{"key":"459_CR48","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1111\/j.1550-7408.1989.tb02670.x","volume":"36","author":"SL Stringer","year":"1989","unstructured":"Stringer SL et al (1989) Sequence from ribosomal RNA of Pneumocystis carinii compared to those of four fungi suggests an ascomycetous affinity. J Protozool 36:14S\u201316S","journal-title":"J Protozool"},{"key":"459_CR49","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.meegid.2008.05.001","volume":"8","author":"CM Aliouat-Denis","year":"2008","unstructured":"Aliouat-Denis CM et al (2008) Pneumocystis species, co-evolution and pathogenic power. Infect Genet Evol 8:708\u2013726","journal-title":"Infect Genet Evol"},{"key":"459_CR50","first-page":"13","volume":"43","author":"JK Frenkel","year":"1976","unstructured":"Frenkel JK (1976) Pneumocystis jiroveci n. sp. from man: morphology, physiology, and immunology in relation to pathology. Natl Cancer Inst Monogr 43:13\u201330","journal-title":"Natl Cancer Inst Monogr"},{"issue":"Suppl","key":"459_CR51","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1550-7408.2003.tb00655.x","volume":"50","author":"SP Keely","year":"2003","unstructured":"Keely SP et al (2003) Evolution and speciation of Pneumocystis. J Eukaryot Microbiol 50(Suppl):624\u2013626","journal-title":"J Eukaryot Microbiol"},{"key":"459_CR52","doi-asserted-by":"crossref","first-page":"e00428","DOI":"10.1128\/mBio.00428-12","volume":"4","author":"OH Cisse","year":"2012","unstructured":"Cisse OH et al (2012) De novo assembly of the Pneumocystis jirovecii genome from a single bronchoalveolar lavage fluid specimen from a patient. MBio 4:e00428\u201312","journal-title":"MBio"},{"key":"459_CR53","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/AAC.13.6.975","volume":"13","author":"RM Kluge","year":"1978","unstructured":"Kluge RM et al (1978) Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother 13:975\u2013978","journal-title":"Antimicrob Agents Chemother"},{"key":"459_CR54","first-page":"571","volume":"95","author":"FW Chandler","year":"1979","unstructured":"Chandler FW et al (1979) Pneumocystis pneumonia. Animal model: Pneumocystis cartinii pneumonia in the immunosuppressed rat. Am J Pathol 95:571\u2013574","journal-title":"Am J Pathol"},{"key":"459_CR55","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0022-3476(73)80113-1","volume":"82","author":"WT Hughes","year":"1973","unstructured":"Hughes WT et al (1973) Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr 82:404\u2013415","journal-title":"J Pediatr"},{"key":"459_CR56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","volume":"322","author":"J Phair","year":"1990","unstructured":"Phair J et al (1990) The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med 322:161\u2013165","journal-title":"N Engl J Med"},{"key":"459_CR57","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1172\/JCI114621","volume":"85","author":"J Shellito","year":"1990","unstructured":"Shellito J et al (1990) A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest 85:1686\u20131693","journal-title":"J Clin Invest"},{"key":"459_CR58","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1128\/IAI.01329-06","volume":"75","author":"XL Rudner","year":"2007","unstructured":"Rudner XL et al (2007) Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 75:3055\u20133061","journal-title":"Infect Immun"},{"key":"459_CR59","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","volume":"452","author":"JD Milner","year":"2008","unstructured":"Milner JD et al (2008) Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773\u2013776","journal-title":"Nature"},{"key":"459_CR60","first-page":"e23435","volume":"2","author":"TH Mogensen","year":"2013","unstructured":"Mogensen TH (2013) STAT3 and the Hyper-IgE syndrome: clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties. JAKSTAT 2:e23435","journal-title":"JAKSTAT"},{"key":"459_CR61","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty S (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29:621\u2013663","journal-title":"Annu Rev Immunol"},{"key":"459_CR62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.20111229","volume":"210","author":"D Kotlarz","year":"2013","unstructured":"Kotlarz D et al (2013) Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med 210:433\u2013443","journal-title":"J Exp Med"},{"key":"459_CR63","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.4049\/jimmunol.176.10.6147","volume":"176","author":"FE Lund","year":"2006","unstructured":"Lund FE et al (2006) B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol 176:6147\u20136154","journal-title":"J Immunol"},{"key":"459_CR64","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10875-013-9951-9","volume":"33","author":"BK Al-Saud","year":"2013","unstructured":"Al-Saud BK et al (2013) Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients. J Clin Immunol 33:1325\u20131335","journal-title":"J Clin Immunol"},{"key":"459_CR65","unstructured":"Tsai HY et al. 2012. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients. J Microbiol Immunol Infect"},{"key":"459_CR66","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.aller.2010.12.003","volume":"39","author":"BT Costa-Carvalho","year":"2011","unstructured":"Costa-Carvalho BT et al (2011) Pulmonary complications in patients with antibody deficiency. Allergol Immunopathol (Madr) 39:128\u2013132","journal-title":"Allergol Immunopathol (Madr)"},{"key":"459_CR67","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI13826","volume":"108","author":"M Zheng","year":"2001","unstructured":"Zheng M et al (2001) CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. J Clin Invest 108:1469\u20131474","journal-title":"J Clin Invest"},{"key":"459_CR68","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/IAI.70.3.1069-1074.2002","volume":"70","author":"F Gigliotti","year":"2002","unstructured":"Gigliotti F et al (2002) Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect Immun 70:1069\u20131074","journal-title":"Infect Immun"},{"key":"459_CR69","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1172\/JCI119384","volume":"99","author":"AH Limper","year":"1997","unstructured":"Limper AH et al (1997) The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J Clin Invest 99:2110\u20132117","journal-title":"J Clin Invest"},{"key":"459_CR70","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1074\/jbc.M611686200","volume":"282","author":"ME Lasbury","year":"2007","unstructured":"Lasbury ME et al (2007) Polyamine-mediated apoptosis of alveolar macrophages during Pneumocystis pneumonia. J Biol Chem 282:11009\u201311020","journal-title":"J Biol Chem"},{"key":"459_CR71","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.20030932","volume":"198","author":"C Steele","year":"2003","unstructured":"Steele C et al (2003) Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J Exp Med 198:1677\u20131688","journal-title":"J Exp Med"},{"key":"459_CR72","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/IAI.74.1.390-393.2006","volume":"74","author":"J Wells","year":"2006","unstructured":"Wells J et al (2006) Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia. Infect Immun 74:390\u2013393","journal-title":"Infect Immun"},{"key":"459_CR73","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.4049\/jimmunol.172.2.1132","volume":"172","author":"F McAllister","year":"2004","unstructured":"McAllister F et al (2004) T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice. J Immunol 172:1132\u20131138","journal-title":"J Immunol"},{"key":"459_CR74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1258\/ijsa.2009.008521","volume":"20","author":"S Mori","year":"2009","unstructured":"Mori S, Levin P (2009) A brief review of potential mechanisms of immune reconstitution inflammatory syndrome in HIV following antiretroviral therapy. Int J STD AIDS 20:447\u2013452","journal-title":"Int J STD AIDS"},{"key":"459_CR75","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/QCO.0b013e328352b664","volume":"25","author":"G Martin-Blondel","year":"2012","unstructured":"Martin-Blondel G et al (2012) Pathogenesis of the immune reconstitution inflammatory syndrome in HIV-infected patients. Curr Opin Infect Dis 25:312\u2013320","journal-title":"Curr Opin Infect Dis"},{"key":"459_CR76","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","volume":"10","author":"M Muller","year":"2010","unstructured":"Muller M et al (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10:251\u2013261","journal-title":"Lancet Infect Dis"},{"key":"459_CR77","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/cid\/cir802","volume":"54","author":"CJ Achenbach","year":"2012","unstructured":"Achenbach CJ et al (2012) Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin Infect Dis 54:424\u2013433","journal-title":"Clin Infect Dis"},{"key":"459_CR78","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/QAD.0b013e3283511e91","volume":"26","author":"RM Novak","year":"2012","unstructured":"Novak RM et al (2012) Immune reconstitution inflammatory syndrome: incidence and implications for mortality. AIDS 26:721\u2013730","journal-title":"AIDS"},{"key":"459_CR79","doi-asserted-by":"crossref","first-page":"e11416","DOI":"10.1371\/journal.pone.0011416","volume":"5","author":"PM Grant","year":"2010","unstructured":"Grant PM et al (2010) Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS ONE 5:e11416","journal-title":"PLoS ONE"},{"key":"459_CR80","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/QAD.0b013e32832d9b20","volume":"23","author":"P Jagannathan","year":"2009","unstructured":"Jagannathan P et al (2009) Life-threatening immune reconstitution inflammatory syndrome after Pneumocystis pneumonia: a cautionary case series. AIDS 23:1794\u20131796","journal-title":"AIDS"},{"key":"459_CR81","doi-asserted-by":"crossref","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","volume":"4","author":"A Zolopa","year":"2009","unstructured":"Zolopa A et al (2009) Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE 4:e5575","journal-title":"PLoS ONE"},{"key":"459_CR82","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1165\/ajrcmb.17.4.2851","volume":"17","author":"TW Wright","year":"1997","unstructured":"Wright TW et al (1997) Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice. Am J Respir Cell Mol Biol 17:491\u2013500","journal-title":"Am J Respir Cell Mol Biol"},{"key":"459_CR83","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1172\/JCI6688","volume":"104","author":"TW Wright","year":"1999","unstructured":"Wright TW et al (1999) Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest 104:1307\u20131317","journal-title":"J Clin Invest"},{"key":"459_CR84","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4049\/jimmunol.0901864","volume":"184","author":"SP Bhagwat","year":"2010","unstructured":"Bhagwat SP et al (2010) Anti-CD3 antibody decreases inflammation and improves outcome in a murine model of Pneumocystis pneumonia. J Immunol 184:497\u2013502","journal-title":"J Immunol"},{"key":"459_CR85","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1128\/IAI.00668-06","volume":"74","author":"F Gigliotti","year":"2006","unstructured":"Gigliotti F et al (2006) Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia. Infect Immun 74:6310\u20136316","journal-title":"Infect Immun"},{"key":"459_CR86","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2353\/ajpath.2006.050724","volume":"168","author":"SD Swain","year":"2006","unstructured":"Swain SD et al (2006) CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice. Am J Pathol 168:466\u2013475","journal-title":"Am J Pathol"},{"key":"459_CR87","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO;2-#","volume":"32","author":"S Hori","year":"2002","unstructured":"Hori S et al (2002) CD25+ CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 32:1282\u20131291","journal-title":"Eur J Immunol"},{"key":"459_CR88","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1128\/IAI.70.11.6107-6113.2002","volume":"70","author":"S Ruan","year":"2002","unstructured":"Ruan S et al (2002) Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection. Infect Immun 70:6107\u20136113","journal-title":"Infect Immun"},{"key":"459_CR89","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.4049\/jimmunol.177.9.6215","volume":"177","author":"L McKinley","year":"2006","unstructured":"McKinley L et al (2006) Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. J Immunol 177:6215\u20136226","journal-title":"J Immunol"},{"key":"459_CR90","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1128\/IAI.69.2.758-764.2001","volume":"69","author":"TW Wright","year":"2001","unstructured":"Wright TW et al (2001) Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect Immun 69:758\u2013764","journal-title":"Infect Immun"},{"key":"459_CR91","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.4049\/jimmunol.0802775","volume":"182","author":"EN Atochina-Vasserman","year":"2009","unstructured":"Atochina-Vasserman EN et al (2009) Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation. J Immunol 182:2277\u20132287","journal-title":"J Immunol"},{"key":"459_CR92","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1128\/IAI.01181-12","volume":"81","author":"MJ Linke","year":"2013","unstructured":"Linke MJ et al (2013) Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia. Infect Immun 81:984\u2013995","journal-title":"Infect Immun"},{"key":"459_CR93","doi-asserted-by":"crossref","unstructured":"Ricks D et al. 2013. Dectin immunoadhesins and Pneumocystis pneumonia. Infect Immun","DOI":"10.1128\/IAI.00136-13"},{"key":"459_CR94","unstructured":"Bellamy RJ. 2008. HIV: treating Pneumocystis pneumonia (PCP). Clin Evid (Online) 2008"},{"key":"459_CR95","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/jac\/dkp372","volume":"64","author":"J Helweg-Larsen","year":"2009","unstructured":"Helweg-Larsen J et al (2009) Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. J Antimicrob Chemother 64:1282\u20131290","journal-title":"J Antimicrob Chemother"},{"key":"459_CR96","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/clinids\/4.2.426","volume":"4","author":"H Jick","year":"1982","unstructured":"Jick H (1982) Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 4:426\u2013428","journal-title":"Rev Infect Dis"},{"key":"459_CR97","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/ACI.0b013e32825ea68a","volume":"7","author":"E Phillips","year":"2007","unstructured":"Phillips E, Mallal S (2007) Drug hypersensitivity in HIV. Curr Opin Allergy Clin Immunol 7:324\u2013330","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"459_CR98","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/383034","volume":"38","author":"HH Hirsch","year":"2004","unstructured":"Hirsch HH et al (2004) Immune reconstitution in HIV-infected patients. Clin Infect Dis 38:1159\u20131166","journal-title":"Clin Infect Dis"},{"key":"459_CR99","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1468-1293.2002.00115.x","volume":"3","author":"SM Barry","year":"2002","unstructured":"Barry SM et al (2002) Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med 3:207\u2013211","journal-title":"HIV Med"},{"key":"459_CR100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1086\/341974","volume":"35","author":"CE Koval","year":"2002","unstructured":"Koval CE et al (2002) Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. Clin Infect Dis 35:491\u2013493","journal-title":"Clin Infect Dis"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-014-0459-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-014-0459-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-014-0459-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T22:14:46Z","timestamp":1566080086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-014-0459-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,25]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1007\/s00281-014-0459-z","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,25]]}}}